How Bacteria Break Through The Blood-Brain Barrier

The bacteria that sneak past the brain's defenses to cause deadly bacterial meningitis are clever adversaries - they convince their host that they are harmless yet then have freedom to cause disease by taking advantage of a molecular warning signal and inducing the brain's cellular armor to temporarily break down, letting in the bacterial horde.
The blood-brain barrier is a thin network of blood vessels whose cells abut each other very closely, forming protein junctions too tight for bacteria and viruses to fit through. The barrier's purpose is to prevent unwanted material from crossing over from the surrounding bloodstream into brain tissue.
"You can think of the blood-brain barrier as a brick wall," explains Brandon Kim, a biology graduate student at San Diego State University. "Each cell of the blood-brain barrier is a brick and these tight junctions are the mortar."
Like castle guards, the cells that form this barrier can selectively let through nutrients and other "approved" molecules needed for normal brain function.
When bacteria or viruses do manage to slip past the blood-brain barrier and infect brain tissue, it can result in bacterial meningitis, a frequently deadly disease caused when the brain becomes dangerously inflamed.
Using cell cultures, zebrafish and mice as models, the authors investigated how one type of bacteria, group B streptococcus, gets through the brain's defenses.
By observing the bacteria's advance at different points in time and analyzing which molecular processes were active at the time, the researchers discovered an interesting result. When receptors along the blood side of the blood-brain barrier detect group B strep, the system fires off a molecular "danger" signal. However, tied into this protective molecular signal is another detrimental signal.
Stranger danger
When these blood-brain barrier cells fire off their danger signal, it not only induces the brain's molecular "help" response but also induces a gene to produce a transcription factor protein known as Snail1 that contributes the breakdown of the barrier's tight junctions. In doing so, the barrier unwittingly destroys its own integrity and permits the bacteria to enter the brain.
This study is the first to look at Snail1 in the context of meningitis. Previous research has described Snail1 as a factor of invasive cancer.
Understanding this process could allow scientists to develop therapeutics that temporarily control Snail1 expression and prevent the blood-brain barrier from acting on the hijacked self-destruct signal. Additionally, it might also allow researchers to harness the same process for good, designing drugs that tell the blood-brain barrier to let them through so they can fight various brain diseases.


Comments

Post a Comment

Popular posts from this blog

Fussy eaters: the favoured food of Salmonella

Image
As antibiotic resistance increases the search for new anti-bacterial treatments becomes more and more important. One way to design anti-bacterials is to find specific biochemical pathways that the bacteria require to survive, and develop drugs that block off these pathways. Some pathways are better targets than others and for  Salmonella bacteria it was thought that pathways dealing with nutrient metabolises would be a lost cause. Salmonella lives in the intestine, which hosts a whole variety of different nutrients, so surely preventing the bacteria from using a specific one wouldn’t cause them much undue distress. It’s been found, however, that as they grow and spread in the inflamed intestine the bacteria are heavily reliant on one particular nutrient: fructose-asparagine. The chemical structure of fructose-asparagine, image from the reference. The importance of fructose-asparagine metabolism was originally discovered durin...
Read more

Timing is key for bacteria surviving antibiotics

For bacteria facing a dose of antibiotics, timing might be the key to evading destruction. In a series of experiments, Princeton researchers found that cells that repaired DNA damaged by antibiotics before resuming growth had a much better chance of surviving treatment. When antibiotics hit a population of bacteria, often a small fraction of "persister" cells survive to pose a threat of recurrent infection. Unlike bacteria with genetic resistance to antibiotics, evidence suggests that persisters stay alive in part by stalling cellular processes targeted by the drugs. In a new study, Princeton researchers examined a class of antibiotics that target bacterial DNA. In bacterial populations, some cells repair damaged DNA before resuming growth, and others resume growth before making repairs. The researchers found that those that make repairs before resuming growth generally are the ones that survive as persisters. The research advances a long-term goal to make ...
Read more